These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35921289)

  • 1. TP53 mutation detected in circulating exosomal DNA is associated with prognosis of patients with hepatocellular carcinoma.
    Li Y; Wu J; Li E; Xiao Z; Lei J; Zhou F; Yin X; Hu D; Mao Y; Wu L; Wenjun L
    Cancer Biol Ther; 2022 Dec; 23(1):439-445. PubMed ID: 35921289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
    Peng SY; Chen WJ; Lai PL; Jeng YM; Sheu JC; Hsu HC
    Int J Cancer; 2004 Oct; 112(1):44-50. PubMed ID: 15305374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive Value of the
    Yu X; Mao SQ; Shan YY; Huang Y; Wu SD; Lu CD
    Genet Test Mol Biomarkers; 2022 Oct; 26(10):476-484. PubMed ID: 36264169
    [No Abstract]   [Full Text] [Related]  

  • 4. Droplet digital PCR detects high rate of TP53 R249S mutants in cell-free DNA of middle African patients with hepatocellular carcinoma.
    Marchio A; Amougou Atsama M; Béré A; Komas NP; Noah Noah D; Atangana PJA; Camengo-Police SM; Njouom R; Bekondi C; Pineau P
    Clin Exp Med; 2018 Aug; 18(3):421-431. PubMed ID: 29749584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
    Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
    Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
    [No Abstract]   [Full Text] [Related]  

  • 6. Circulating tumor DNA correlates with microvascular invasion and predicts tumor recurrence of hepatocellular carcinoma.
    Wang J; Huang A; Wang YP; Yin Y; Fu PY; Zhang X; Zhou J
    Ann Transl Med; 2020 Mar; 8(5):237. PubMed ID: 32309384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
    Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
    World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer.
    Bernard V; Kim DU; San Lucas FA; Castillo J; Allenson K; Mulu FC; Stephens BM; Huang J; Semaan A; Guerrero PA; Kamyabi N; Zhao J; Hurd MW; Koay EJ; Taniguchi CM; Herman JM; Javle M; Wolff R; Katz M; Varadhachary G; Maitra A; Alvarez HA
    Gastroenterology; 2019 Jan; 156(1):108-118.e4. PubMed ID: 30240661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nomogram to predict microvascular invasion in early hepatocellular carcinoma.
    Li H; Li T; Hu J; Liu J
    J Cancer Res Ther; 2021 Jul; 17(3):652-657. PubMed ID: 34269295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When to call it off: defining transplant candidacy limits in liver donor liver transplantation for hepatocellular carcinoma.
    Bhatti ABH; Qureshi AI; Tahir R; Dar FS; Khan NY; Zia HH; Riyaz S; Rana A
    BMC Cancer; 2020 Aug; 20(1):754. PubMed ID: 32787864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Image-matching digital macro-slide-a novel pathological examination method for microvascular invasion detection in hepatocellular carcinoma.
    Yu HM; Wang K; Feng JK; Lu L; Qin YC; Cheng YQ; Guo WX; Shi J; Cong WM; Lau WY; Dong H; Cheng SQ
    Hepatol Int; 2022 Apr; 16(2):381-395. PubMed ID: 35294742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of molecular characteristics of hepatocellular carcinoma with microvascular invasion based on deep targeted sequencing.
    Zheng L; Wang Y; Liu Z; Wang Z; Tao C; Wu A; Li H; Xiao T; Li Z; Rong W
    Cancer Med; 2024 Apr; 13(7):e7043. PubMed ID: 38572921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of TP53 Mutation for Transcatheter Arterial Chemoembolization Failure/Refractoriness in HBV-Related Advanced Hepatocellular Carcinoma.
    Xue M; Wu Y; Fan W; Guo J; Wei J; Wang H; Tan J; Wang Y; Yao W; Zhao Y; Li J
    Cancer Res Treat; 2020 Jul; 52(3):925-937. PubMed ID: 32229792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-derived proliferative CTCs and CTC clusters predict aggressiveness and early recurrence in hepatocellular carcinoma patients.
    Zhao L; Song J; Sun Y; Ju Q; Mu H; Dong X; Ding J; Liu Y; Wang X; Sun L; Wu J; Jiao Y; Lu S; Zhao X
    Cancer Med; 2023 Jul; 12(13):13912-13927. PubMed ID: 37337648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel prognostic nomogram based on microvascular invasion and hematological biomarkers to predict survival outcome for hepatocellular carcinoma patients.
    Li X; Huang H; Yu X; Chen P; Ouyang J; Huang B
    Surg Oncol; 2020 Jun; 33():51-57. PubMed ID: 32561099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Utility of Protein Induced by Vitamin K Absence-II in Patients with Hepatocellular Carcinoma.
    Bhatti ABHH; Naz K; Abbas G; Khan NY; Zia HH; Ahmed IN
    Asian Pac J Cancer Prev; 2021 Jun; 22(6):1731-1736. PubMed ID: 34181327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TP53 R249S mutation detected in circulating tumour DNA is associated with Prognosis of hepatocellular carcinoma patients with or without hepatectomy.
    Shen T; Li SF; Wang JL; Zhang T; Zhang S; Chen HT; Xiao QY; Ren WH; Liu C; Peng B; Ji XN; Yang Y; Lu PX; Chen TY; Yu L; Ji Y; Jiang DK
    Liver Int; 2020 Nov; 40(11):2834-2847. PubMed ID: 32594568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessments of TP53 and CTNNB1 gene hotspot mutations in circulating tumour DNA of hepatitis B virus-induced hepatocellular carcinoma.
    Kumar S; Nadda N; Quadri A; Kumar R; Paul S; Tanwar P; Gamanagatti S; Dash NR; Saraya A; Shalimar ; Nayak B
    Front Genet; 2023; 14():1235260. PubMed ID: 37593116
    [No Abstract]   [Full Text] [Related]  

  • 19. High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy.
    Lv Y; Wang W; Jia WD; Sun QK; Huang M; Zhou HC; Xia HH; Liu WB; Chen H; Sun SN; Xu GL
    Eur J Surg Oncol; 2013 Oct; 39(10):1129-35. PubMed ID: 23916473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlation of perioperative alpha-fetoprotein expression in peripheral blood to recurrence of hepatocellular carcinoma].
    Shi M; Zhang Y; Zhong C; Lin XJ; Zhang CQ; Li JQ
    Ai Zheng; 2008 Jan; 27(1):83-7. PubMed ID: 18184471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.